Molecure Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Molecure stock has a consensus rating of "Strong Buy" and an average price target of zł 12.45. The average 1-year stock price forecast is 118.42% higher than the current stock price, while the lowest is zł 9.90 (+73.68%) and the highest is zł 15.00 (+163.16%).

Price Target: zł 12.45 (+118.42%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	zł 9.90	zł 12.45	zł 12.45	zł 15.00
Change	+73.68%	+118.42%	+118.42%	+163.16%

Analyst Ratings

The average analyst rating for Molecure stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Oct '25	Jan '26	Mar '26	Apr '26	May '26
Strong Buy	2	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Financial Forecast

Revenue This Year

13.10M

from 6.52M

100.94%

from 6.52M

Revenue Next Year

32.90M

from 13.10M

151.15%

from 13.10M

EPS This Year

-1.80

from -

EPS Next Year

-1.70

from -1.80

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.17M	7.51M	3.65M	2.92M	6.52M	13.10M
Revenue Growth	-99.07%	543.32%	-51.39%	-20.08%	123.34%	100.94%
Operating Income	-13.76M	-37.67M	-32.13M	-32.30M	-16.56M	-71.20M
Net Income	-13.64M	-35.95M	-28.37M	-31.29M	-15.69M	-71.60M
EPS	-	-	-	-	-	-1.80
No. Analysts	-	-	-	-	-	1

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is PLN.

Revenue Forecast

Revenue	2026	2027
High	13.1M
Avg	13.1M
Low	13.1M

Revenue Growth

Revenue Growth	2026	2027
High	100.9%
Avg	100.9%
Low	100.9%

EPS Forecast

EPS	2026	2027
High	-
Avg	-1.80
Low	-

EPS Growth

EPS Growth	2026	2027
High	-
Avg	-
Low	-